Cyclin-dependent kinase 7 inhibitors

The present invention relates to novel compounds of formula I, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, which exhibit the properties of a CDK7 inhibitor, as well as to a pharmaceutical composition containing said compounds, methods for treating diseases or disorders, a...

Full description

Saved in:
Bibliographic Details
Main Authors SMOLNIKOV, SERGEI ALEXANDROVICH, CHESTNOVA, ANNA YURIEVNA, SHPAKOVA, ELENA ALEXANDROVNA, EFIMENKO, NIKITA IGOREVICH, GOLUBEV, ARTEM ALEKSEEVICH, SHARKOV, DMITRII EVGENIEVICH, CHEREMUSHKIN, ANDREI IVANOVICH, GORBUNOVA, SVETLANA, LENSHMIDT, LILIANA VYACHESLAVOVNA, VIKENTEVA, YULIA ARTUROVNA, MOROZOV, DMITRY VALENTINOVICH, VORONKOVA, MARIA SERGEEVNA, KISELEV, MAKSIM ALEKSANDROVICH, IAKOVLEV, DANILA ALEKSEEVICH, LUKASHENKO, ANTON VLADIMIROVICH, MIKHAYLOV, LEONID EVGEN'EVICH
Format Patent
LanguageChinese
English
Published 01.06.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel compounds of formula I, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, which exhibit the properties of a CDK7 inhibitor, as well as to a pharmaceutical composition containing said compounds, methods for treating diseases or disorders, and the use of said compounds or composition as pharmaceutical preparations for treating diseases or disorders.
Bibliography:Application Number: TW202312136149